Differentiation and cancer in the mammary gland: shedding light on an old dichotomy
- PMID: 9709809
- PMCID: PMC3867313
- DOI: 10.1016/s0065-230x(08)60741-1
Differentiation and cancer in the mammary gland: shedding light on an old dichotomy
Abstract
In this brief review, the development of breast cancer is discussed from the vantage of phenotypic differentiation, similar to what has been considered over the years for leukemias and melanomas, both of which express easily visible differentiation markers (Hart and Easty, 1991; Clarke et al., 1995; Lynch, 1995; Sachs, 1996; Sledge, 1996). The review is divided into a theoretical background for human breast differentiation and a discussion of recent experimental results in our laboratories with differentiation of breast epithelial cells. In the theoretical background, in situ markers of differentiation of normal breast and carcinomas are discussed with emphasis on their possible implications for tumor therapy. So far, most of the emphasis regarding differentiation therapy of tumors has been focused on the possible action of soluble factors, such as colony-stimulating factors in leukemias and retinoic acids in solid tumors (Lotan, 1996; Sachs, 1996). However, an emerging and promising new avenue in this area appears to point to additional factors, such as the cellular form and extracellular matrix (ECM) (Bissel et al., 1982; Bissel and Barcellos-Hoff, 1987; Ingber, 1992). The recent interest in these parameters has evolved along with an increasing understanding of the molecular composition of the ECM, and of the molecular basis of the classical findings that normal cell--in contrast to tumor cells--are anchorage dependent for survival and growth (Folkman and Moscona, 1978; Hannigan et al., 1996). We now know that this is the case for epithelial as well as fibroblastic cells, and that interaction with ECM is crucial for such regulation. Indeed, ECM and integrins are emerging as the central regulators of differentiation, apoptosis, and cancer (Boudreau et al., 1995; Boudreau and Bissel, 1996; Werb et al., 1996; Bissell, 1997; Weaver, et al., 1997). In the experimental part, we elaborate on our own recent experiments with functional culture models of the human breast, with particular emphasis on how "normal" and cancer cells could be defined within a reconstituted ECM. Special attention is given to integrins, the prominent ECM receptors. We further discuss a number of recent experimental results, all of which point to the same conclusion: namely that phenotypic reversion toward a more normal state for epithelial tumors is no longer an elusive goal. Thus "therapy by differentiation" could be broadened to include not only blood-borne tumors, but also solid tumors of epithelial origin.
Figures




Similar articles
-
Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma.J Cell Sci. 1995 May;108 ( Pt 5):1945-57. doi: 10.1242/jcs.108.5.1945. J Cell Sci. 1995. PMID: 7544798
-
Integrins in mammary gland development and differentiation of mammary epithelium.J Mammary Gland Biol Neoplasia. 2003 Oct;8(4):383-94. doi: 10.1023/B:JOMG.0000017426.74915.b9. J Mammary Gland Biol Neoplasia. 2003. PMID: 14985635 Review.
-
Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9064-8. doi: 10.1073/pnas.89.19.9064. Proc Natl Acad Sci U S A. 1992. PMID: 1384042 Free PMC article.
-
Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.Cancer Res. 2000 Jan 15;60(2):439-49. Cancer Res. 2000. PMID: 10667599
-
Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer.Cell Adh Migr. 2014;8(6):588-94. doi: 10.4161/19336918.2014.972788. Cell Adh Migr. 2014. PMID: 25482625 Free PMC article. Review.
Cited by
-
Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.Mol Cell Biol. 2001 Aug;21(16):5488-99. doi: 10.1128/MCB.21.16.5488-5499.2001. Mol Cell Biol. 2001. PMID: 11463831 Free PMC article.
-
Intrauterine breast development and the mammary myoepithelial lineage.J Mammary Gland Biol Neoplasia. 2005 Jul;10(3):199-210. doi: 10.1007/s10911-005-9581-9. J Mammary Gland Biol Neoplasia. 2005. PMID: 16807800 Review.
-
The mammary myoepithelial cell--Cinderella or ugly sister?Breast Cancer Res. 2001;3(1):1-4. doi: 10.1186/bcr260. Epub 2000 Nov 2. Breast Cancer Res. 2001. PMID: 11250738 Free PMC article. Review.
-
Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture.BMC Res Notes. 2010 Jul 7;3:184. doi: 10.1186/1756-0500-3-184. BMC Res Notes. 2010. PMID: 20609224 Free PMC article.
-
Perspectives on tissue interactions in development and disease.Curr Mol Med. 2010 Feb;10(1):95-112. doi: 10.2174/156652410791065363. Curr Mol Med. 2010. PMID: 20205682 Free PMC article. Review.